Canara Robeco Emerging Equities Fund: Focusing on Long Term View
Listen to Canara Robeco Emerging Equities Fund: Focusing on Long Term View
00:00
00:00
After moderate recovery in April, markets turned volatile again in May. Recent relief package/s the government announced to fight the numbing impact of COVID-19 failed to cheer the market, while the extension of the lockdown further raised concerns over economic growth.
However, it is advantageous to stay invested even during an economic slowdown to reap the benefits of revival in demand. A short-term approach to investment tends to be very risky and may not pay off in the long term.
Large & mid cap funds come with the dual advantage of stability of large caps and high growth potential of mid caps which can efficiently aid in long-term appreciation of wealth.
Canara Robeco Emerging Equities Fund (CREEF) is one such large & mid cap fund that endeavors to identify companies which have the potential to become leaders of tomorrow in their respective sectors within the large and midcap space.
Graph 1: Growth of Rs 10,000 if invested in Canara Robeco Emerging Equities Fund 5 years ago
CREEF is an aggressively managed large & mid cap fund that has a superior performance track record. Over the last five years, CREEF has generated returns at 7.9% CAGR in comparison to about 3.9% CAGR generated by its benchmark Nifty LargeMidcap 250 - TRI index. The fund has thus outpaced the benchmark by a noticeable margin of around 4 percentage points. Much of the outperformance over the index, in the last 5 years, has been registered during the mid and small cap rally seen in 2016-2017, when its portfolio was biased towards mid and small caps. In the current corrective phase, the fund has managed to restrict the downside reasonably well.
Data as on May 27, 2020
(Source: ACE MF)
Table: Canara Robeco Emerging Equities Fund's performance vis-a-vis category peers
Returns are point to point and in %, calculated using Direct Plan - Growth option. Those depicted over 1-Yr are compounded annualised.
Data as on May 27, 2020
(Source: ACE MF)
*Please note, this table only represents the best performing funds based solely on past returns and is NOT a recommendation. Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator for future returns. The percentage returns shown are only for indicative purposes.
CREEF has delivered substantial returns over its benchmark and the category average across various time periods. On a 5-year and 7-year returns basis, the fund has outperformed the benchmark Nifty LargeMidcap 250 - TRI by a CAGR of around 4 to 9 percentage points. Even on a shorter duration of 1 year to 3 years, the fund has been ahead of the benchmark.
Over longer time periods, CREEF easily ranks among the top schemes, and makes the list of prime contenders. Some of the other top contenders during the period are Invesco India Growth Opp Fund, Mirae Asset Emerging Bluechip Fund, and Kotak Equity Opportunities Fund.
In terms of risk, the fund's volatility is among the lowest in the category, whereas its risk-adjusted returns denoted by Sharpe is among the best.
Investment strategy of Canara Robeco Emerging Equities Fund
Categorised as a large & midcap fund, CREEF has a mandate to invest a minimum 35% of its assets in large-caps with a simultaneous investment of at least 35% in mid-caps. The fund currently has a balanced exposure across both large caps and midcaps and holds a well-diversified portfolio of 55 to 65 stocks, with focus on quality, growth, and valuation.
CREEF uses a mix of top-down and bottom-up approaches to pick high growth and quality stocks from the eligible universe of companies in the large and mid-cap space and applies diversification well to manage downside risk. The core focus of the fund is on picking cash flow generating businesses at a reasonable valuation.
Graph 2: Top portfolio holdings in Canara Robeco Emerging Equities Fund
Holding in (%) as on April 30, 2020
(Source: ACE MF)
As on April 30, 2020, CREEF held a well-diversified portfolio of 53 stocks. The top 10 stocks constitute 35% of its assets with HDFC Bank having the highest allocation of 6.1%. Reliance Industries, ICICI Bank, Ipca Laboratories and Atul are some of the other top holdings of the fund. Notably, CREEF has a long tail of about 23 stocks having exposure of less than 1% in each stock.
CREEF was early to judge the potential of mid and small cap stocks like Navin Flourine International, Ipca Laboratories, Atul, Divi's Laboratories, Whirlpool of India, Indraprastha Gas, Gujarat Gas, among others that have turned out to be major contributors to its returns over the last 1 year.
The top 5 sectors in the fund's portfolio currently account for around 63% of its holdings. Finance stocks are the fund's top sectoral bets, followed by Engineering, Consumption, Transportation and Oil & Gas.
Suitability
CREEF makes good use of diversification across stocks, sectors, and market capitalisation to manage risk. This has helped the fund in delivering superior risk-adjusted returns over different time periods as compared to its benchmark and category peers. The fund invests in high conviction companies with a long term view and aims to stay away from herd behaviour, chasing short term profits. CREEF's higher allocation to large and midcaps along with lower levels of exposure to small caps can help it create long-term wealth, albeit at a higher risk. This makes the fund suitable for aggressive investors having high risk appetite and an investment horizon of more than five years.
Warm Regards,
Divya Grover
Research Analyst
Editor's note: The last few years have not been among the best for equity mutual funds. While most funds have underperformed or are struggling to match the returns of the benchmark, there are few funds that have the potential to constantly generate alpha for its investors. And we have identified five such high alpha generating funds, in our latest report 'The Alpha Funds Report 2020'. Do not miss our latest research finding. Get your access to this exclusive report, right here!
Note: This write up is for information purpose and does not constitute any kind of investment advice or a recommendation to Buy / Hold / Sell a fund. Returns mentioned herein are in no way a guarantee or promise of future returns. As an investor, you need to pick the right fund to meet your financial goals. If you are not sure about your risk appetite, do consult your investment consultant/advisor. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.
Join Now: PersonalFN is now on Telegram. Join FREE Today to get ‘Daily Wealth Letter’ and Exclusive Updates on Mutual Funds
DISCLOSURE AS PER SECURITIES AND EXCHANGE BOARD OF INDIA (RESEARCH ANALYSTS) REGULATIONS, 2014
About the Company including business activity
Quantum Information Services Private Limited (QIS) was incorporated on December 19, 1989.
QIS was promoted by Mr Ajit Dayal with an objective of providing value-based information/views on news related to equity markets, the economy in general, sector analysis, budget review and various personal products and investments options available to the Public. It was the first company to start equity research on an institutional level.
'PersonalFN' is a service brand of QIS and was started in the year 1999. In 1999, the Company registered the Domain name www.personalfn.com for providing information on mutual funds and personal financial planning, financial markets in general, etc. and services related to financial planning and research in various financial instruments including mutual funds, insurance and fixed income products to customers. It offers asset allocation and researched investment recommendations through its financial planning services.
Quantum Information Services Private Limited (QIS) is registered as Investment Adviser under SEBI (Investment Adviser) Regulations, 2013 and having Registration No.: INA000000680. In terms of the second proviso to Regulation 3 (1) of SEBI (Research Analysts) Regulations, 2014 the Company is not required to obtain Certificate of registration from SEBI.
Disciplinary history
There are no outstanding litigations against the Company, its subsidiaries and its Directors.
Terms and condition on which its offer research report
For the terms and condition for research report click here.
Details of associates
-
Money Simplified Services Private Limited;
-
PersonalFN Insurance Services India Private Limited;
-
Equitymaster Agora Research Private Limited;
-
Common Sense Living Private Limited;
-
Quantum Advisors Private Limited;
-
Quantum Asset Management Company Private Limited;
-
HelpYourNGO.com India Private Limited;
-
HelpYourNGO Foundation;
-
Natural Streets for Performing Arts Foundation;
-
Primary Real Estate Advisors Private Limited;
-
HYNGO India Private Limited;
-
Rahul Goel;
-
I V Subramaniam.
Disclosure with regard to ownership and material conflicts of interest
-
‘subject company’ is a scheme on which a buy/sell/hold view or target price is given/changed in this Research Report;
-
Neither QIS, it's Associates, Research Analyst or his/her relative have any financial interest in the subject Company; except for one of the Research Analysts holding units of Canara Robeco Emerging Equities Fund;
-
Neither QIS, it's Associates, Research Analyst or his/her relative have actual/beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report;
-
Neither QIS, it's Associates, Research Analyst or his/her relative has any other material conflict of interest at the time of publication of the research report except that QIS (PersonalFN) is, as per SEBI (Mutual Funds) Regulations 1996, an associate / group Company of Quantum Asset Management Company Private Limited and Trustees and Sponsor of Quantum Mutual Fund (QMF) and to that extent there may be conflict of interest while recommending any schemes of QMF. However, any such recommendation or reference made is based on the standard evaluation and selection process, which applies uniformly for all Mutual Fund Schemes. The payment of commission (upfront / annualized & trail), if any, for any Schemes by QMF to QIS (PersonalFN) is also at arm's length and as per prevailing market practices.
Disclosure with regard to receipt of Compensation
-
Neither QIS nor it's Associates have received any compensation from the subject Company in the past twelve months;
-
Neither QIS nor it's Associates have managed or co-managed public offering of securities for the subject Company;
-
Neither QIS nor it's Associates have received any compensation for investment banking or merchant banking or brokerage services from the subject Company;
-
Neither QIS nor it's Associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months.
-
Neither QIS nor it's Associates have received any compensation or other benefits from the subject Company or third party in connection with the research report
General disclosure
-
The Research Analyst has not served as an officer, director or employee of the subject Company.
-
QIS or the Research Analyst has not been engaged in market making activity for the subject Company.
Click here to read PersonalFN's Mutual Fund Rating Methodology
Subject Company means Mutual Fund Schemes
Quantum Information Services Private Limited CIN: U65990MH1989PTC054667 Regd. Office: 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021 Corp. Office: 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021.
Email:info@personalfn.com Website: www.personalfn.com Tel.: 022 61361200 Fax.: 022 61361222 SEBI-registered Investment Adviser. Registration No. INA000000680, SEBI (Investment Advisers) Regulation, 2013